Vertex Pharmaceuticals (NASDAQ: VRTX)
Vertex Pharmaceuticals Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Vertex Pharmaceuticals Company Info
Vertex is in the business of discovering, developing, and commercializing small-molecule drugs for the treatment of serious genetic diseases including cystic fibrosis.
News & Analysis
7 Reasons Why Vertex Pharmaceuticals Is a No-Brainer Stock to Buy on the Dip
There's more good news than bad news for this big biotech stock.
2 Top Stocks I Wouldn't Hesitate to Invest $1,000 in Right Now
These growth stocks have plenty of room to run.
The 3 Things That Matter for Vertex Pharmaceuticals Now
Some of these developments could improve the company's prospects.
3 Top Growth Stocks to Buy in the Second Half of 2025
Top ETFs Tracking CRISPR Gene Editing
These exchange-traded funds track companies in this biotech space.
3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow
3 Top Growth Stocks to Buy in the Second Half of 2025
This Stock Just Dropped by 12% in 1 Day. History Says This Will Happen Next
Valuation
Podcast Episodes
Alleged Industrial Espionage Makes an Interesting Story
We also chat about Vertex Pharmaceuticals and its role at the center of cystic fibrosis treatment.
3 Biotech Companies Analyzed
We examine three biotech companies' past performances and future outlooks.
Is Amarin's Fish Oil Pill on Track to Become a Blockbuster?
Plus, how gene-editing company CRISPR Therapeutics just took a big step forward.
Earnings Transcripts
Vertex Pharmaceuticals (VRTX) Q4 2024 Earnings Call Transcript
VRTX earnings call for the period ending December 31, 2024.
Vertex Pharmaceuticals (VRTX) Q3 2024 Earnings Call Transcript
VRTX earnings call for the period ending September 30, 2024.
Vertex Pharmaceuticals (VRTX) Q2 2024 Earnings Call Transcript
VRTX earnings call for the period ending June 30, 2024.
Vertex Pharmaceuticals (VRTX) Q1 2024 Earnings Call Transcript
VRTX earnings call for the period ending March 31, 2024.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.